Everand Logo

Welcome to Everand!

  • STAT

    So much for Trump’s rule about drug prices in TV ads

    An insider's guide to the politics and policy of health care.
    by Nicholas Florko Jul 09, 2019 5 minutes

    D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

    Drug industry 1, Trump administration 0

    It’s official: The Trump administration does not have the authority to force drug makers to disclose their sticker prices in TV ads, at least according to a ruling released late Monday from D.C. District Court Judge Amit Mehta, who blocked the proposal just hours before it was set to go into effect today. For more on that ruling, check out my story here.

    I’ll be watching to see how the administration pivots from this painful defeat. It’s been more than a year since the Trump administration first released its largely aspirational “drug pricing blueprint” in May 2018, and before Monday, this was the only real accomplishment Trump could point to. Now that point

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
    Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.
    STAT1 min read
    Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
    HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
    STAT1 min read
    STAT+: Pharmalittle: We’re Watching BIO Layoffs, AstraZeneca Plans To Double Revenue, And More
    The Biotechnology Innovation Organization on Monday announced 30 layoffs that are part of a restructuring.

    Related Books & Audiobooks